FDA official logo
GSRS logo
PFDA official logo

OCRELIZUMAB

  • UNII: A10SJL62JY
  • Preferred Substance Name: OCRELIZUMAB

  • 637334-45-3
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULFIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER
  • IMMUNOGLOBULIN G1, ANTI-(HUMAN CD20 (ANTIGEN)) (HUMAN-MOUSE MONOCLONAL 2H7 .GAMMA.1-CHAIN), DISULPHIDE WITH HUMAN-MOUSE MONOCLONAL 2H7 .KAPPA.-CHAIN, DIMER
  • OCRELIZUMAB [INN]
  • OCRELIZUMAB [JAN]
  • OCRELIZUMAB [MI]
  • OCRELIZUMAB [PURPLE BOOK, CDER]
  • OCRELIZUMAB [USAN]
  • OCRELIZUMAB [WHO-DD]
  • OCREVUS
  • PR070769
  • PR-070769
  • R-1594
  • RG-1594

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.